According to Transgene SA's latest financial reports the company's current EPS (TTM) is -2,12 โฌ. In 2022 the company made an earnings per share (EPS) of -0,31 โฌ a decrease over its 2021 EPS that were of -0,21 โฌ.
Year | EPS | Change |
---|---|---|
2022 | -0,31 โฌ | 48.16% |
2021 | -0,21 โฌ | -6.93% |
2020 | -0,23 โฌ | -0.6% |
2019 | -0,23 โฌ | -273.41% |
2018 | 0,13 โฌ | -124.48% |
2017 | -0,54 โฌ | 31.82% |
2016 | -0,41 โฌ | -63.87% |
2015 | -1,12 โฌ | -14.59% |
2014 | -1,32 โฌ | -17.15% |
2013 | -1,59 โฌ | 2.99% |
2012 | -1,54 โฌ | 0.3% |
2011 | -1,54 โฌ | 8.93% |
2010 | -1,41 โฌ | -7.32% |
2009 | -1,52 โฌ | 56.96% |
2008 | -0,97 โฌ | 176.84% |
2007 | -0,35 โฌ | -77.81% |
2006 | -1,58 โฌ | -18.58% |
2005 (TTM) | -1,94 โฌ | -25.92% |
2004 | -2,62 โฌ | 18.71% |
2003 | -2,21 โฌ | 35.08% |
2002 | -1,63 โฌ | -16.55% |
2001 | -1,96 โฌ | -37.1% |
2000 | -3,11 โฌ | 18.51% |
1999 | -2,63 โฌ | -60.26% |
1998 | -6,61 โฌ | 109.21% |
1997 | -3,16 โฌ |